Banner - Collaborative Care Symposium

News
Media
Conferences
Blog
Publications
Partners
Resources
Subscribe
CE

Elad Kedar

Articles by Elad Kedar

FDA approves low-dose pilocarpine hydrochloride 0.4% as a treatment for presbyopia

ByLynda Charters,Emily Kaiser Maharjan, Assistant Managing Editor,Elad Kedar,Paul Smith

October 18th 2023

Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.

Pipeline: Presbyopia treatment to finish Phase 3 late 2021

ByElad Kedar,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

June 4th 2021

Orasis Pharmaceuticals drop in development for treating presbyopia

Latest Updated Articles

Pipeline: Presbyopia treatment to finish Phase 3 late 2021
Published: June 4th 2021 | Updated:

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

AAOpt 2025: Retaining contact lens patients with Dr Susan Gromacki

The (nursery) rhyme and reason behind blinking

© 2025 MJH Life Sciences^®

All rights reserved.